Skip to main content
. 2020 May 15;10:8031. doi: 10.1038/s41598-020-64635-8

Table 2.

Correlation between specific mutation and recurrence risk in T4 well differentiated thyroid cancer.

Mutation Positive, estimated 3-year recurrence rate Mutation Negative, estimated 3-year recurrence rate p-value
BRAF V600E positive (n = 7) 47.37% 0.00% p = 0.04*
TERT positive (n = 2) 50.00% 19.70% p = 0.22
BRAF and TERT positive (n = 12) 58.30% 16.48% p = 0.05*